to give written informed consent. 5. Patients with cognitive impairment unable to comply with treatment programme. 6. Patients with a serious disorder of bone metabolism other than osteoporosis (e.g., endocrinebonediseases, osteomalacia and Paget's disease)Contacts and LocationsGo to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts